HRP20171871T1 - Spojevi aluminija za uporabu u terapeutskim proizvodima i cjepivima - Google Patents

Spojevi aluminija za uporabu u terapeutskim proizvodima i cjepivima

Info

Publication number
HRP20171871T1
HRP20171871T1 HRP20171871TT HRP20171871T HRP20171871T1 HR P20171871 T1 HRP20171871 T1 HR P20171871T1 HR P20171871T T HRP20171871T T HR P20171871TT HR P20171871 T HRP20171871 T HR P20171871T HR P20171871 T1 HRP20171871 T1 HR P20171871T1
Authority
HR
Croatia
Prior art keywords
vaccines
therapeutics
aluminium compounds
aluminium
compounds
Prior art date
Application number
HRP20171871TT
Other languages
English (en)
Inventor
Michael Möhlen
Michael Weber
Jürgen WRUSS
Robert Schlegl
Original Assignee
Valneva Austria Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47294919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20171871(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2012/054387 external-priority patent/WO2013135274A1/en
Application filed by Valneva Austria Gmbh filed Critical Valneva Austria Gmbh
Publication of HRP20171871T1 publication Critical patent/HRP20171871T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HRP20171871TT 2011-12-06 2017-12-04 Spojevi aluminija za uporabu u terapeutskim proizvodima i cjepivima HRP20171871T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11192230 2011-12-06
PCT/EP2012/054387 WO2013135274A1 (en) 2012-03-13 2012-03-13 Aluminium compounds for use in therapeutics and vaccines
EP16183076.5A EP3106176B1 (en) 2011-12-06 2012-12-06 Aluminium compounds for use in therapeutics and vaccines

Publications (1)

Publication Number Publication Date
HRP20171871T1 true HRP20171871T1 (hr) 2018-01-12

Family

ID=47294919

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20171871TT HRP20171871T1 (hr) 2011-12-06 2017-12-04 Spojevi aluminija za uporabu u terapeutskim proizvodima i cjepivima

Country Status (15)

Country Link
EP (4) EP2788023B1 (hr)
CY (1) CY1119927T1 (hr)
DE (1) DE202012012768U1 (hr)
DK (6) DK2788023T3 (hr)
ES (2) ES2647882T3 (hr)
FI (1) FI3785730T3 (hr)
HR (1) HRP20171871T1 (hr)
HU (1) HUE037325T2 (hr)
LT (1) LT3106176T (hr)
NO (1) NO3106176T3 (hr)
PL (2) PL3106176T3 (hr)
PT (2) PT3106176T (hr)
RS (1) RS56709B1 (hr)
SI (1) SI3106176T1 (hr)
WO (1) WO2013083726A1 (hr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2788023T3 (en) 2011-12-06 2016-12-19 Valneva Austria Gmbh Aluminum compounds for use in therapeutics and vaccines
US9895437B2 (en) 2012-04-18 2018-02-20 Valneva Austria Gmbh Aluminum compounds for use in therapeutics and vaccines
WO2016034610A1 (en) * 2014-09-03 2016-03-10 Intervet International B.V. Attenuated bovine coronavirus and related vaccines
HRP20230273T1 (hr) 2015-12-23 2023-04-28 Valneva Austria Gmbh Cjepivo protiv zika virusa
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
NZ761619A (en) 2017-09-21 2024-03-22 Valneva Se Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus chikv-delta5nsp3
BR112020008652A2 (pt) 2017-11-03 2020-11-10 Takeda Vaccines, Inc. vacinas e composições imunogênicas contra zika e métodos de uso das mesmas
AU2018375173B2 (en) 2017-11-30 2022-08-25 Takeda Vaccines, Inc. Zika vaccines and immunogenic compositions, and methods of using the same
US20210275662A1 (en) 2018-07-13 2021-09-09 Valneva Se Method for rescuing and producing a virus in avian cells
WO2020234300A1 (en) 2019-05-20 2020-11-26 Valneva Se A subunit vaccine for treatment or prevention of a respiratory tract infection
MX2022010642A (es) * 2020-03-01 2022-11-08 Dynavax Tech Corp Vacunas contra coronavirus que comprenden un agonista de tlr9.
AU2021229710A1 (en) 2020-03-01 2022-10-06 Dynavax Technologies Corporation CPG-adjuvanted SARS-CoV-2 virus vaccine
WO2021178318A1 (en) * 2020-03-01 2021-09-10 Dynavax Technologies Corporation Coronavirus vaccines comprising a tlr9 agonist
US20230110516A1 (en) * 2020-03-01 2023-04-13 Dynavax Technologies Corporation Coronavirus vaccines comprising a tlr9 agonist
EP3895729A1 (en) 2020-03-01 2021-10-20 Valneva Austria GmbH Cpg-adjuvanted sars-cov-2 virus vaccine
UY39159A (es) 2020-04-06 2021-10-29 Valneva Austria Gmbh VACUNA INACTIVADA CONTRA EL VIRUS DEL SARS-CoV-2
US20230398210A1 (en) 2020-04-09 2023-12-14 Valneva Austria Gmbh Improvements in vaccine formulations for medical use
EP4319802A2 (en) 2021-04-09 2024-02-14 Valneva SE Human metapneumovirus combination vaccine
WO2023148256A1 (en) 2022-02-02 2023-08-10 Valneva Austria Gmbh Inactivated sars-cov-2 virus vaccine
WO2023232901A1 (en) 2022-06-01 2023-12-07 Valneva Austria Gmbh Clostridium difficile vaccine

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4761372A (en) 1981-01-12 1988-08-02 New York University Mutant enterotoxin of E. coli
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4761283A (en) 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4882317A (en) 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US5308835A (en) 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
NL8802046A (nl) 1988-08-18 1990-03-16 Gen Electric Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
CA2059693C (en) 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
AUPO264096A0 (en) 1996-09-30 1996-10-24 Mclaughlin Geosurveys Pty Ltd. Value improvement of clays
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
DE69837211T2 (de) 1997-08-28 2007-12-06 Cheil Jedang Corp. Ein an vero-zellen angepasstes abgeschwächtes japanische enzephalitis virus und ein impfstoff gegen japanische enzephalitis
AU771330B2 (en) 1998-08-19 2004-03-18 Baxter Healthcare Sa Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
PT1372708E (pt) 2001-02-13 2008-09-29 Us Gov Sec Army Vacina para imunização transcutânea
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
US20110189217A1 (en) * 2008-06-26 2011-08-04 Barry Michael A Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
CN101734698B (zh) 2009-09-08 2013-01-09 东北大学 一种由含铝物料制备氧化铝的方法
DK2788023T3 (en) 2011-12-06 2016-12-19 Valneva Austria Gmbh Aluminum compounds for use in therapeutics and vaccines

Also Published As

Publication number Publication date
NO3106176T3 (hr) 2018-03-10
DK3269386T3 (da) 2022-10-24
ES2930458T3 (es) 2022-12-13
FI3785730T3 (fi) 2024-05-06
DK2788023T3 (en) 2016-12-19
EP3106176B1 (en) 2017-10-11
DK3785730T3 (da) 2024-05-06
PL3269386T3 (pl) 2022-12-05
PL3106176T3 (pl) 2018-03-30
DK201300194U1 (da) 2014-01-17
EP3269386B1 (en) 2022-09-14
HUE037325T2 (hu) 2018-08-28
DK3106176T3 (en) 2018-01-08
DE202012012768U1 (de) 2014-01-21
EP2788023A1 (en) 2014-10-15
ES2647882T3 (es) 2017-12-27
EP3785730B1 (en) 2024-04-24
CY1119927T1 (el) 2018-12-12
PT3269386T (pt) 2022-12-05
EP3785730A1 (en) 2021-03-03
EP2788023B1 (en) 2016-11-02
SI3106176T1 (en) 2018-04-30
LT3106176T (lt) 2018-01-10
RS56709B1 (sr) 2018-03-30
EP3269386A1 (en) 2018-01-17
WO2013083726A1 (en) 2013-06-13
DK201300193U1 (da) 2014-01-17
PT3106176T (pt) 2017-12-20
EP3106176A1 (en) 2016-12-21

Similar Documents

Publication Publication Date Title
HRP20171871T1 (hr) Spojevi aluminija za uporabu u terapeutskim proizvodima i cjepivima
HK1202086A1 (en) Calcimimetics and methods for their use
GB201120993D0 (en) Novel compounds and their use in therapy
GB201111705D0 (en) Compounds and their use
HK1191034A1 (en) N-carboxyalkyl-auristatins and use thereof n-
EP2676566A4 (en) CASE AND STOP FOR VALISE HANDLE
HK1198115A1 (en) Improvements in lockers
IL231082A0 (en) Pyrimido-pyridazinone compounds and their use
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
EP2739318A4 (en) INLINE STERILIZER
SG10201606161UA (en) Albumin Formulation and Use
EP2688588A4 (en) FAST AND LONG-TERM IMMUNOLOGICAL THERAPEUTIC
GB201111630D0 (en) Novel compounds and their use
EP2817304A4 (en) NOVEL COMPOUNDS AND THEIR THERAPEUTIC USE
EP2697386A4 (en) DESIGN AND USE OF PEPDUCINE
GB201114448D0 (en) Compounds and their use
PL2591798T3 (pl) Szczepionka do zastosowania w immunoterapii nowotworów
GB201218084D0 (en) Novel compounds and methods for use in medicine
EP2657245A4 (en) FRUCTOSYLATED MANGIFERIN, MANUFACTURING METHOD AND ITS USE
HK1198587A1 (en) Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals -2-
GB201121833D0 (en) Aluminium compounds for use in therapeutics and vaccines
IL229936B (en) Albumin formulation and use
GB201104444D0 (en) Compounds and their use
GB201112578D0 (en) Pharmaceutical preparation and use
GB201117984D0 (en) In line hairdryer